Literature DB >> 15770497

Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion.

Peter Kossmehl1, Johann Schönberger, Mehdi Shakibaei, Shideh Faramarzi, Ekkehard Kurth, Britta Habighorst, Rüdiger von Bauer, Markus Wehland, Reinhold Kreutz, Manfred Infanger, Gundula Schulze-Tanzil, Martin Paul, Daniela Grimm.   

Abstract

Following a severe ischemic injury or myocardial infarction, the extracellular matrix (ECM) of the heart is involved in pathophysiological conditions such as dilatation and cardiac dysfunction. Osteopontin (OPN) has been shown to interact with fibronectin suggesting its possible role in matrix organization, stability and wound healing. There is increased expression of OPN in several tissues in response to injury. Therefore, we tested the hypothesis that acute ischemia (2 h), followed by reperfusion (4 h) may induce early OPN and fibronectin in an isolated hemoperfused working porcine heart model. Twenty hearts were prepared and connected to a perfusion system. After 1 h of perfusion, these hearts were randomized to two groups: ten infarcted (MI, ramus circumflexus) and ten non-infarcted hearts (C). In addition, cardiac fibroblasts derived from infarcted, remote and control myocardium were investigated. In both groups, the heart rate, electrolytes, pH, blood gases, and lactate remained similar. The LVEDP and perfusion pressure of MI hearts increased significantly (P<0.05). The total fibronectin and OPN volume contents were clearly elevated in the infarct area. The matrix metalloproteinases (MMP-1 and MMP-8), fibronectin, OPN, TGF-beta1 proteins and the mRNAs for fibronectin, TGF-beta1, and OPN were significantly elevated in the infarct area as compared to the remote area and the non-infarcted hearts. Simultaneously, circulating carboxyterminal propeptide of type I procollagen (PICP) was released in the perfusion medium (threefold versus C). Fibroblast-like cells originating from the infarct area exhibited an enhanced OPN and fibronectin gene and protein expression compared to fibroblasts derived from control myocardium. Our data demonstrate the early appearance of the MMPs (increased collagen degrading enzymes) and PICP (a collagen synthesis marker) following ischemia and reperfusion. Moreover, OPN, fibronectin and TGF-beta1 protein and gene expression are elevated after ischemia and reperfusion in the ex vivo working hemoperfused porcine heart model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770497     DOI: 10.1007/s00109-005-0642-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  45 in total

Review 1.  Cytokines and the microcirculation in ischemia and reperfusion.

Authors:  N G Frangogiannis; K A Youker; R D Rossen; M Gwechenberger; M H Lindsey; L H Mendoza; L H Michael; C M Ballantyne; C W Smith; M L Entman
Journal:  J Mol Cell Cardiol       Date:  1998-12       Impact factor: 5.000

2.  TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.

Authors:  Hongjiang Chen; Dayuan Li; Tom Saldeen; Jawahar L Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05       Impact factor: 4.733

Review 3.  Unravelling the mysteries of collagen and cicatrix after myocardial infarction.

Authors:  P Whittaker
Journal:  Cardiovasc Res       Date:  1995-06       Impact factor: 10.787

4.  Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion.

Authors:  A A Knowlton; C M Connelly; G M Romo; W Mamuya; C S Apstein; P Brecher
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

5.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Myocardial osteopontin expression coincides with the development of heart failure.

Authors:  K Singh; G Sirokman; C Communal; K G Robinson; C H Conrad; W W Brooks; O H Bing; W S Colucci
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

Review 7.  Fibronectin and wound healing.

Authors:  F Grinnell
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

8.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture. A preliminary report.

Authors:  S M Factor; T F Robinson; R Dominitz; S H Cho
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

10.  Collagen loss in the stunned myocardium.

Authors:  R H Charney; S Takahashi; M Zhao; E H Sonnenblick; C Eng
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

View more
  14 in total

Review 1.  The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation.

Authors:  Christopher J Wingard; Dianne M Walters; Brook L Cathey; Susana C Hilderbrand; Pranita Katwa; Sijie Lin; Pu Chun Ke; Ramakrishna Podila; Apparao Rao; Robert M Lust; Jared M Brown
Journal:  Nanotoxicology       Date:  2010-11-03       Impact factor: 5.913

5.  Impact of simulated microgravity on microvascular endothelial cell apoptosis.

Authors:  Chun-Yan Kang; Lin Zou; Ming Yuan; Yang Wang; Tian-Zhi Li; Ye Zhang; Jun-Feng Wang; Yan Li; Xiao-Wei Deng; Chang-Ting Liu
Journal:  Eur J Appl Physiol       Date:  2011-02-02       Impact factor: 3.078

6.  Osteopontin is proteolytically processed by matrix metalloproteinase 9.

Authors:  Merry L Lindsey; Fouad A Zouein; Yuan Tian; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás
Journal:  Can J Physiol Pharmacol       Date:  2015-03-26       Impact factor: 2.273

7.  Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment.

Authors:  James E Ip; Yaojiong Wu; Jing Huang; Lunan Zhang; Richard E Pratt; Victor J Dzau
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

8.  Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.

Authors:  Raffaele Altara; Marco Manca; Ramzi Sabra; Assaad A Eid; George W Booz; Fouad A Zouein
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

9.  Novel cardiac-specific biomarkers and the cardiovascular continuum.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Athanasios Didangelos; Morten A Karsdal
Journal:  Biomark Insights       Date:  2012-05-02

Review 10.  Danger signals in the initiation of the inflammatory response after myocardial infarction.

Authors:  J J de Haan; M B Smeets; G Pasterkamp; F Arslan
Journal:  Mediators Inflamm       Date:  2013-11-30       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.